A rising number of people have accepted GLP-1s as a way to treat obesity, which affects more than 100 million Americans.

These compounds take a different approach to weight loss than existing medications, which can cause nausea, vomiting and ...

Cost is a major obstacle for many. The drugs can be expensive without insurance, with out-of-pocket expenses reaching ...

A new poll from The Associated Press-NORC Center for Public Affairs Research shows about half of U.S. adults believe it is a good thing for adults to use weight-loss drugs like Ozempic, Wegovy and ...

One recent analysis found that, over the course of three years, people taking semaglutide (the compound in Ozempic and the weight loss drug Wegovy) were about 40 to 70 percent less likely to be ...

Scouted selects products independently. If you purchase something from our posts, we may earn a small commission. Unless you ...

While Hannah hasn't found the drug to be useful for weight loss, six months on, she's more than willing to keep paying the ...

CBS News Miami investigates the financial hurdles surrounding these medications and explores alternatives that may offer a ...

Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...

Although RMD has re-rated from its share price low of around $21.50 in October 2023, it has only just surpassed its all-time ...

More than half of adults with overweight or obesity prescribed a GLP-1 discontinue their drug within 1 year, with discontinuation rates higher for those without type 2 diabetes, researchers reported ...

Roche Holding AG delivered a strong set of 2024 earnings. Guidance for 2025 suggests this will be a transitional year ahead, ...